Craneware (LON:CRW)‘s stock had its “buy” rating restated by Peel Hunt in a note issued to investors on Friday.
Separately, Berenberg Bank restated a “buy” rating and issued a GBX 3,600 ($47.04) price target on shares of Craneware in a research note on Monday, November 26th.
Shares of LON CRW opened at GBX 2,930 ($38.29) on Friday. Craneware has a 12-month low of GBX 1,170 ($15.29) and a 12-month high of GBX 2,040 ($26.66).
Craneware Company Profile
Craneware plc engages in the development, licensing, and ongoing support of computer software for the United States healthcare industry. The company offers patient engagement solutions that enhance patient satisfaction with billing by providing accurate out-of-pocket estimates and mobile-friendly payment plans; reduce bad debt and ineffective paper collections with upfront patient engagement and point-of-service collections; and provide all-payor medical necessity validation and prior authorization coverage to ensure accuracy and prevent denials.
Featured Article: Preferred Stock
Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with MarketBeat.com's FREE daily email newsletter.